OUTCOMES OF INTERMEDIATE AND HIGH-RISK NEUROBLASTOMA PATIENTS TREATED WITH PROTON BEAM THERAPY
Love Goyal(Cancer Research UK), Ed Smith(University of Manchester), Marianne Aznar, N. Thorp(The Christie Hospital), Shermaine Pan(Proton (United Kingdom)), Yuwei Wang, Abiola Fatmilehin(The Christie NHS Foundation Trust), Mohamedkhalid Abutaleb(The Christie NHS Foundation Trust)
Cited by 0
Related Papers
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal|2022|2.7k
2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
|European Heart Journal - Cardiovascular Imaging|2022|486
The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer
|Annals of Oncology|2022|138
Life Cycle Assessment of Solar Photovoltaic Microgrid Systems in Off-Grid Communities
|Environmental Science & Technology|2016|87
Cardiovascular Considerations Before Cancer Therapy
|JACC CardioOncology|2024|53